UK Regulator Gives Unilever and McCormick Until Nov. 18 to Fix Competition Concerns or Face Deeper Probe into $65 Billion Food Merger — BigGo Finance
UK's CMA gave Unilever (UL) and McCormick (MKC) until Nov. 18 to address competition concerns over their $65B food merger or face a deeper probe. The regulator found the deal could reduce competition in dry ingredient mixes and sauces. Both companies are cooperating. McCormick shares fell 2.1% in London trading. The merger, expected to close mid-2027, would create a $65B company with $600M in annual cost synergies.
How this was made
The 30-second read
Why it matters
A Nov. 18 remedy deadline is the key near-term catalyst. Failure to propose acceptable remedies could trigger a phase-two investigation, extending timelines and increasing uncertainty for both deal completion and any required asset sales.
Market read
Traders should focus on the Nov. 18 remedy submission outcome, which can shift deal probability and expected closing timing for both UL and MKC.
What to watch
The CMA’s product-market distinction for mustard reduces one divestiture need (Colmans), which may simplify remedies and improve odds of clearance before mid-2027.
Background
The CMA is conducting an initial review of Unilever and McCormick’s planned $65B food combination and has identified competition concerns in dry ingredient mixes and dry sauces to UK retailers.
Ticker impact
UK CMA set a Nov. 18 deadline for Unilever to propose remedies or face a phase-two probe into its $65B food merger with McCormick.
Likely downside pressure as markets price higher probability of a phase-two referral and delayed closing.
The article describes a hard regulatory deadline tied to competition concerns in dry ingredient mixes and dry sauces, with phase-two as the next step if remedies are not proposed.
McCormick faces the same Nov. 18 CMA remedy deadline for competition concerns tied to the planned $65B Unilever food combination.
Likely negative bias as investors weigh the probability of a phase-two investigation and remedy complexity.
The CMA initial review found substantial competition weakening risk in dry ingredient mixes and dry sauces, and the article frames Nov. 18 as the near-term catalyst.
Market effects
Highlights heightened UK antitrust scrutiny for large branded food ingredient suppliers, potentially raising deal-risk premia for similar consolidation.
UK regulatory process could delay cross-border food M&A timelines and increase uncertainty for UK consumer packaged goods.
US HSR approval already cleared, but UK phase-two risk shows multi-jurisdiction clearance can still derail or delay global closing schedules.
Counterpoint
If a remedy package centered on divesting the Schwartz business is viewed as clean, the phase-two risk could be overstated and the deal could still clear without major structural break.
Key entities
- regulatorCompetition and Markets Authority (CMA)
UK antitrust regulator overseeing the initial and potential phase-two review of the Unilever-McCormick merger.
- companyUnilever
Food business acquirer in the planned combination, facing a Nov. 18 remedy deadline.
- companyMcCormick
Spices and sauces company partnering with Unilever, facing the same Nov. 18 remedy deadline.
- companyNestle
Mentioned as a rival supplier (Maggi) in dry ingredient mixes, used to illustrate competitive discipline.
- companyPremier Foods
Mentioned as a rival supplier (Bisto) in dry sauces, used to illustrate competitive discipline.
